The anti-tumor effect of TMZ alone was significantly different in HCT-116+ch3 cells (MMR-proficient) and was less pronounced in HCT-116 and HCT-116-APC(KD) cells (Fig. 6B). This evidence concerns the gene APC and neoplasm.